AVTX vs IP · P/E 0.0, rev $441.0K vs P/E 43, $26.62B cap
Avalo Therapeutics Inc (AVTX) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
IP does not have a complete income-statement cache yet.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the AVTX and IP stock pages for the full models.
Not investment advice.